Jane Lo
Merck & Co.
2 Papers
43 Citations
Jane Lo is an academic researcher from Merck & Co.. The author has contributed to research in topics: Gonadotropin-releasing hormone & 5-Lipoxygenase-Activating Protein Inhibitors. The author has an hindex of 2, co-authored 2 publications.
Chat about Author
Papers
Quinolones as gonadotropin releasing hormone (GnRH) antagonists: simultaneous optimization of the C(3)-aryl and C(6)-substituents.
Jonathan R. Young,Song X. Huang,Irene Chen,Thomas F. Walsh,Robert J. DeVita,Matthew J. Wyvratt,Mark T. Goulet,Ning Ren,Jane Lo,Yi Tien Yang,Joel B. Yudkovitz,Kang Cheng,Roy G. Smith +12 more
TL;DR: A series of 3-arylquinolones was prepared and evaluated for their ability to act as gonadotropin releasing hormone (GnRH) antagonists and the 3,4,5-trimethylphenyl substituent (23h) was found to be optimal.
26
Evaluation of endo- and exo-aryl-substitutions and central scaffold modifications on diphenyl substituted alkanes as 5-lipoxygenase activating protein inhibitors
Lin Chu,Helen M. Armstrong,Linda L. Chang,Amy F. Cheng,Lawrence F. Colwell,Jisong Cui,Jilly F. Evans,Amy Galka,Mark T. Goulet,Nancy S. Hayes,Jane Lo,John G. Menke,Hyun O. Ok,Debra Ondeyka,Minal Patel,Grace M. Quaker,Heather L. Sings,Stephanie L. Witkin,Annie Zhao,Feroze Ujjainwalla +19 more
TL;DR: A search for a suitable replacement for the central norbornyl scaffold presented in the recently disclosed novel FLAP inhibitors is herein described, as well as the SAR study performed on the endo and exo-aryl groups.
21